Physician
Potomac Pathology PLLC
Potomac Pathology PLLC was paid $108K by Medicaid between Jan 2018 and May 2024, across 48 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 90% of everything it billed.
33Billing provider infoPOTOMAC PATHOLOGY PLLC
WOODBRIDGE, VA 22191
WOODBRIDGE, VA 22191
33aNPI1932424157assigned 03/30/2010
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$108K
24GClaims7,675
24DCodes billed48
24AFirst – last monthJan 2018 – May 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Virginia
Rank by total paid#16 of 63
Median peer was paid$6K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 483 | $9K | |
| 2019 | 4,636 | $28K | |
| 2020 | 551 | $19K | |
| 2021 | 517 | $15K | |
| 2022 | 725 | $17K | |
| 2023 | 620 | $16K | |
| 2024incomplete | 143 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 90% | 2,960 | 2,665 | $98K |
| 85060 | 4.5% | 349 | 314 | $5K | |
| 88304 | 2.6% | 338 | 317 | $3K | |
| 88307 | 1.5% | 26 | 25 | $2K | |
| 88342 | <1% | 19 | 13 | $586.07 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 25 | 21 | $400.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 747 | 498 | $11.04 |
| 82247 | 0% | 23 | 13 | $0.00 | |
| 85014 | 0% | 122 | 98 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 17 | 15 | $0.00 |
| 84702 | 0% | 35 | 20 | $0.00 | |
| 82248 | 0% | 26 | 15 | $0.00 |
36 more codes
| 81003 | 0% | 20 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 308 | $0.00 |
| 80076 | 0% | 127 | $0.00 | |
| 87210 | 0% | 18 | $0.00 | |
| 85610 | 0% | 58 | $0.00 | |
| 84100 | 0% | 48 | $0.00 | |
| 80061 | Lipid panel | 0% | 14 | $0.00 |
| 81025 | 0% | 16 | $0.00 | |
| 87186 | 0% | 31 | $0.00 | |
| 86900 | 0% | 30 | $0.00 | |
| 84484 | 0% | 184 | $0.00 | |
| 81001 | 0% | 233 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 131 | $0.00 |
| 85027 | 0% | 238 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 203 | $0.00 |
| 86140 | 0% | 20 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 433 | $0.00 |
| 83735 | 0% | 98 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 30 | $0.00 |
| 80047 | 0% | 125 | $0.00 | |
| 82803 | 0% | 44 | $0.00 | |
| 87070 | 0% | 21 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 17 | $0.00 |
| 87040 | 0% | 69 | $0.00 | |
| 83690 | 0% | 93 | $0.00 | |
| 83605 | 0% | 112 | $0.00 | |
| 86901 | 0% | 30 | $0.00 | |
| 85730 | 0% | 24 | $0.00 | |
| 87807 | 0% | 28 | $0.00 | |
| 85379 | 0% | 15 | $0.00 | |
| 86850 | 0% | 14 | $0.00 | |
| 82553 | 0% | 20 | $0.00 | |
| 83880 | 0% | 18 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 67 | $0.00 |
| 87081 | 0% | 14 | $0.00 | |
| 87077 | 0% | 37 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialO'CONNELL, JEROME (PRESIDENT)